These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
646 related articles for article (PubMed ID: 14960647)
21. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study. Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438 [TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus. Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554 [TBL] [Abstract][Full Text] [Related]
23. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. Even-Sapir E J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595 [TBL] [Abstract][Full Text] [Related]
24. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056 [TBL] [Abstract][Full Text] [Related]
25. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence. Metser U; Miller E; Lerman H; Even-Sapir E AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662 [TBL] [Abstract][Full Text] [Related]
26. Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer. Abikhzer G; Srour S; Fried G; Drumea K; Kozlener E; Frenkel A; Israel O; Fogelman I; Kagna O Nucl Med Commun; 2016 Nov; 37(11):1160-8. PubMed ID: 27536906 [TBL] [Abstract][Full Text] [Related]
27. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Beheshti M; Vali R; Waldenberger P; Fitz F; Nader M; Loidl W; Broinger G; Stoiber F; Foglman I; Langsteger W Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1766-74. PubMed ID: 18465129 [TBL] [Abstract][Full Text] [Related]
28. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Chakraborty D; Bhattacharya A; Mete UK; Mittal BR Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596 [TBL] [Abstract][Full Text] [Related]
29. Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice. Bastawrous S; Bhargava P; Behnia F; Djang DS; Haseley DR Radiographics; 2014; 34(5):1295-316. PubMed ID: 25208282 [TBL] [Abstract][Full Text] [Related]
30. [SPECT/CT fusion imaging for the diagnosis of benign and malignant lesions in bones]. Zhao Z; Li FL; Zhao LX; Su MG Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):1036-9. PubMed ID: 19253855 [TBL] [Abstract][Full Text] [Related]
31. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701 [TBL] [Abstract][Full Text] [Related]
33. A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer. Wondergem M; van der Zant FM; van der Ploeg T; Knol RJ Nucl Med Commun; 2013 Oct; 34(10):935-45. PubMed ID: 23903557 [TBL] [Abstract][Full Text] [Related]
34. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients. Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259 [TBL] [Abstract][Full Text] [Related]
35. Performance of 18F-fluoride PET or PET/CT for the detection of bone metastases: a meta-analysis. Shen CT; Qiu ZL; Han TT; Luo QY Clin Nucl Med; 2015 Feb; 40(2):103-10. PubMed ID: 25290289 [TBL] [Abstract][Full Text] [Related]
36. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081 [TBL] [Abstract][Full Text] [Related]
37. Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Li Y; Schiepers C; Lake R; Dadparvar S; Berenji GR Bone; 2012 Jan; 50(1):128-39. PubMed ID: 22001678 [TBL] [Abstract][Full Text] [Related]
38. Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. Moon DH; Maddahi J; Silverman DH; Glaspy JA; Phelps ME; Hoh CK J Nucl Med; 1998 Mar; 39(3):431-5. PubMed ID: 9529287 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of 18F-fluoride PET/MR and PET/CT in patients with foot pain of unclear cause. Rauscher I; Beer AJ; Schaeffeler C; Souvatzoglou M; Crönlein M; Kirchhoff C; Sandmann G; Fürst S; Kilger R; Herz M; Ziegler S; Schwaiger M; Eiber M J Nucl Med; 2015 Mar; 56(3):430-5. PubMed ID: 25678485 [TBL] [Abstract][Full Text] [Related]
40. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]